Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-12

Clinical Trial Update: Liquid Biopsy Under PSMA Radioligand Therapy

View source ↗

Summary

A clinical trial conducted by Würzburg University Hospital is investigating the use of liquid biopsy in patients with metastatic castration-resistant prostate c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lu-177-PSMA-617 (Lutetium-177-PSMA-617)

Snippet

Sponsor: Wuerzburg University Hospital | Conditions: Prostate Cancer Metastatic Castration-Resistant, Prostate Cancer | Status: RECRUITING